References
- Niizuma K. Clinical characteristics of MRSA infections, with particular emphasis on polymicrobial infections. Kansen to Kokinyaku [Infections and Antimicrobials] 2001; 4 Suppl 1: 16–20.
- Tsujino M. Combined effects of antibiotics in the treat-ment of MRSA infections: specifics of use. Kansen to Kokinyaku [Infections and Antimicrobials] 2001; 4 Suppl 1: 27–32.
- Kaatz GW, Seo M, Dorman MJ, et al. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 1990; 162: 103–108.
- Hanaki H. Normal or existent anti-MRSA drugs, and preventive steps of acquisitive resistance. Kagaku Ryoho no Ryoiki [Antibiotics and Chemotherapy] 2001; 17: 233–240.
- Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resis-tant Staphylococcus aureus clinical strain with reduced van-comycin susceptibility. J Antimicrob Chemother 1997; 40: 135–136.
- Toyokawa M, Asari S, Horikawa M, et al. Problems in the checkerboard method using serial twofold dilutions. Nihon Kagaku Ryoho Gakkai Zasshi [Chemotherapy] 1994; 42: 841–848.
- Watanabe A. Current status of antibiotic treatment of MRSA infections and use of anti-MRSA drugs (2) Respiratory infections. Kansen to Kokinyaku [Infections and Antimicrobials] 2001; 4 Suppl 1: 38–43.
- Toyokawa M, Asari S, Horikawa M, et al. In vitro com-bined effects of cefotiam/vancomycin, cefotiam/arbekacin, and minocycline/vancomycin on MRSA. Nihon Kagaku Ryoho Gakkai Zasshi [Chemotherapy] 1996; 44: 590–594.
- Hanaki H, Hiramatsu K. Combination effect of teicoplanin and various antibiotics against hetero-VRSA and VRSA. Kansenshogaku Zasshi [The Journal of the Japanese Assoc. for Infectious Diseases] 1999; 73: 1048–1053.
- Otsuka Y, Yoshibe T, Namioka M, et al. Combination effects of teicoplanin and 13-lactams on MRSA. Jpn J Antibiot 2000; 53: 643–651.
- Tsuji A. Cefozopran II: antibacterial action. Data gath-ered from the 40th Regional New Drug Symposium of the Japan Society of Chemotherapy, Okayama, Japan. December 1992: 19-56.
- Takahashi T, Matsumoto F, Miyazaki S. Comparison of in vitro antibacterial activity of arbekacin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus. Nihon Kagaku Ryoho Gakkai Zasshi [Chemotherapy] 1999; 47: 103–107.